Returning to Orlando for 2023!
At the Gaylord Palms
Looking to the Future of Patient-Centered Care
The 2023 Community Oncology Conference is the premier Conference for independent oncology care teams and stakeholders.
The annual Community Oncology Alliance (COA) Conference is where the biggest issues of the day are discussed. The Enhancing Oncology Model. The Inflation Reduction Act. Practice marketing and advocacy. Direct contracting with employers. Overcoming pharmacy benefit manager abuses. All these issues and more are on the agenda at the 2023 Community Oncology Conference.
Join us for a lively discussion of public policy and regulation, successful practice operations and business strategies, and the latest clinical developments on March 23-24, 2023, right outside Orlando!
Returning to Orlando for 2023!
At the Gaylord Palms
Looking to the Future of Patient-Centered Care
The 2023 Community Oncology Conference is the premier Conference for independent oncology care teams and stakeholders.
The annual Community Oncology Alliance (COA) Conference is where the biggest issues of the day are discussed. The Enhancing Oncology Model. The Inflation Reduction Act. Practice marketing and advocacy. Direct contracting with employers. Overcoming pharmacy benefit manager abuses. All these issues and more are on the agenda at the 2023 Community Oncology Conference.
Join us for a lively discussion of public policy and regulation, successful practice operations and business strategies, and the latest clinical developments on March 23-24, 2023, right outside Orlando!
Returning to Orlando for 2023!
At the Gaylord Palms
Looking to the Future of Patient-Centered Care
The 2023 Community Oncology Conference is the premier Conference for independent oncology care teams and stakeholders.
The annual Community Oncology Alliance (COA) Conference is where the biggest issues of the day are discussed. The Enhancing Oncology Model. The Inflation Reduction Act. Practice marketing and advocacy. Direct contracting with employers. Overcoming pharmacy benefit manager abuses. All these issues and more are on the agenda at the 2023 Community Oncology Conference.
Join us for a lively discussion of public policy and regulation, successful practice operations and business strategies, and the latest clinical developments on March 23-24, 2023, right outside Orlando!
An Agenda for the Future
The agenda for the 2023 Community Oncology Conference looks ahead to what’s coming in health care.
HIGHLIGHTS INCLUDE:
Practice perspectives on the Enhancing Oncology Model
Federal and state policies to curb PBM bad behavior
Working directly with employers
Integrative medicine in cancer
Human resources’ keys to practice success
Enhancing equity in clinical research
Assessing 20 years of advances in cancer care
An Agenda for the Future
The agenda for the 2023 Community Oncology Conference looks ahead to what’s coming in health care.
HIGHLIGHTS INCLUDE:
Practice perspectives on the Enhancing Oncology Model
Federal and state policies to curb PBM bad behavior
Working directly with employers
Integrative medicine in cancer
Human resources’ keys to practice success
Enhancing equity in clinical research
Assessing 20 years of advances in cancer care
Meet Our Fantastic Keynote Speaker
Health care, especially cancer care, can be a humorless arena. At this year’s Community Oncology Conference, we’re tapping into your funny bone and your brain!
Our keynote speaker is Will Flanary, MD, aka Dr. Glaucomflecken. Flanary is well-known to his millions of followers on TikTok, Instagram, Twitter, and YouTube as the doc that cuts through the noise of complicated medical issues with laughter. He frequently comments on the absurdities of the health care system, including hospital bureaucracies, dysfunctional pharmacy benefit managers, and the stereotypical colleagues you might find at any clinic.
World Class Faculty & Speakers
The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.
The 2023 Community Oncology Conference Co-Chairs are:
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network
Kathy Oubre
Pontchartrain Cancer Center
Debra Patt
MD, PhD, MBA
Texas Oncology &
US Oncology
Alti Rahman MHA/MBA, CSSBB
Oncology Consultants
Stephen Schleicher MD, MBA
Tennessee Oncology
World Class Faculty & Speakers
The annual Community Oncology Conference continues to be developed by community oncology providers, administrators, staff, and patients to address their needs in the real world.
The 2023 Community Oncology Conference Co-Chairs are:
Stephen “Fred” Divers, MD
Genesis Cancer & Blood Institute & American Oncology Network
Kathy Oubre
Pontchartrain Cancer Center
Debra Patt
MD, PhD, MBA
Texas Oncology &
US Oncology
Alti Rahman MHA/MBA, CSSBB
Oncology Consultants
Stephen Schleicher MD, MBA
Tennessee Oncology
Jeffrey Vacirca
MD, FACP
New York Cancer & Blood Specialists & OneOncology
Executive Platinum Exhibitors
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on Twitter @AstraZenecaUS.
Follow Us
Bristol Myers Squibb
Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.
Cardinal Health
Daiichi-Sankyo
At Daiichi Sankyo, we create essential medicine for longer, better lives. Every day, we strive to put our skills at the service of those most in need. By uniting cutting-edge science and technology with a genuine interest in people, we develop high-quality, life-changing solutions for the patients of today and tomorrow with great care and unwavering dedication. We rely on reason, ingenuity, perseverance and empathy to make bold strides in oncology.
Our success comes from experts in collaboration: our people, scientists, health care providers, advocates – and patients themselves.
Building on a 120-year heritage and a culture of innovation, we’re forging better futures through medicine for people everywhere. Together, we are creating new standards of care—our contribution to the enrichment of quality of life around the world. Please visit www.daiichisankyo.us.
Flatiron Health®
Flatiron Health is a world leader in transforming patients’ real-life experiences into knowledge to help accelerate improvements in cancer care and treatments.
Follow Us
Genentech
For more than 40 years, we’ve been following the science, seeking solutions to unmet medical needs. As a proud member of the Roche Group, we make medicines to treat patients with serious medical conditions.
We are headquartered in South San Francisco, California.
Incyte
Follow Us
Janssen
At Janssen, we’re creating a future where disease is a thing of the past.We’re thePharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access within genuity, and healing hopelessness with heart.
Follow Us
McKesson
Follow McKesson
Follow The US Oncology Network
Merck
At Merck, our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. The potential to bring new hope to people with cancer drives our purpose and our commitment. As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry across more than 30 tumor types.
Patient Point
PatientPoint® is the patient engagement platform more providers trust. From patient acquisition to in-office and hospital engagement to remote care, our innovative, tech-enabled solutions deliver highly relevant, personalized health experiences across the entire patient journey. More than 140k healthcare providers trust PatientPoint to help them increase practice efficiencies, enhance the patient experience and improve outcomes. See how we can do the same for you. Learn more at patientpoint.com/coa.
Follow Us
Pharmacyclics
Regeneron
Regeneron is a leading science-based biopharmaceutical company that invents, develops and commercializes medicines to treat serious medical conditions.
Follow Us
Gold Exhibitors
Adaptive Biotechnologies
Adaptive Biotechnologies is a commercial-stage biotech company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Our proprietary immune medicine platform reveals and translates the massive genetics of the adaptive immune system with scale, precision and speed. Adaptive’s goal is to develop and commercialize immune-driven diagnostics and therapeutics tailored to each individual patient.
Follow Us
AmerisourceBergen (AB)
AmerisourceBergen (AB) empowers physician practices to deliver quality patient care today and prepare for the challenges of tomorrow. Through our ION Oncology Specialty GPO Network and Oncology Supply specialty distribution, along with our portfolio of integrated solutions and services, we are a unified team of specialty practice partners, committed to building on our legacy of best-in-class service with meaningful innovation that supports our customers as they improve communities through patient-centric care.
Follow Us
Astellas
Astellas –
Astellas is committed to turning innovative science into medical solutions that bring value and hope to patients and their families. Keeping our focus on addressing unmet medical needs and conducting our business with ethics and integrity enables us to improve the health of people throughout the U.S. and around the world.
Astellas Oncology –
Astellas Oncology is committed to elevating the standard of cancer care. We focus on developing innovative, targeted therapies for hard-to-treat cancers with limited treatment options, which is where we see the greatest opportunity to help people living with cancer.
Follow Us
BeiGene
BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. Our 9,000+ employees around the world are committed to expediting the development of a diverse pipeline of novel therapeutics.
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline with the launch of the OncoExTraTM and RiskguardTM tests to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
Eisai Co., Ltd.
At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.
Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US.
Follow Us
Fresenius Kabi
Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. We are a leading provider of generic, medications with 100-year history of delivering innovate therapies that are safe, efficient, and affordable. That’s how we bring confidence within reach.
Follow Us
GSK
Follow Us
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options.
Follow Us
LeanTaaS
LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds. More than 120 health systems and 485 hospitals – including 40% of the top 25 health systems in the country, based on net patient revenue, 80% of all National Comprehensive Cancer Network institutions, and 55% of all National Cancer Institute locations – rely on the company’s iQueue cloud-based platform to increase patient access, decrease wait times, and reduce healthcare delivery costs. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina.
Follow Us
OneOncology
OneOncology was founded by community oncologists, for community oncologists, with the mission of improving the lives of everyone living with cancer.
We are a platform of the nation’s leading independent oncology practices consisting of 940+ providers, practicing at 300+ sites of care and serving over 520,000 patients per year. We are bringing the latest cancer research and treatment options to patients close to home. OneOncology invests in practices to help them grow within their local markets, diversify across multiple specialties, apply data insights, and leverage technology to strengthen performance.
Join the partnership. Drive the future.
Follow Us
Organon
Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines.
Pfizer Oncology
Follow Us
Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to help improve people’s lives. We are working to advance potentially transformative therapies to help people with cancer. Our current work and research focuses on lung, prostate, multiple myeloma and other blood cancers. We take bold steps every day to advance our pipeline and seek solutions that help address critical gaps in care across a variety of difficult-to-treat cancers. Our oncology strategy focuses on developing a portfolio of high-quality assets that we believe will have the potential to improve oncology care.
Silver Exhibitors
American Oncology Network, LLC (AON)
AON serves its expanding network of partner practices by providing over 36 years of proven practice management expertise, dedicated end-to-end administrative support and access to an extensive array of centralized ancillary support services.
AON was recognized on the Inc. 5000 in 2022 as one of the fastest-growing private companies in the nation. Securing the No. 107 overall and No. 8 in the health services category positions, AON continues to grow and serve community oncology practices across the United States.
Follow Us
American Regent, Inc.
American Regent, Inc., a Daiichi Sankyo Group company, is a top-10, US-based injectable drug manufacturer. For over 50 years, American Regent has been developing, manufacturing, and supplying quality generic and branded injectables for healthcare providers and for more than 20 years, we have been a leader in IV iron therapy.
Follow Us
Amgen
Follow Us
Annexus Health
Annexus Health is the leading healthcare technology company that is revolutionizing the patient access journey by delivering innovative solutions, including tech-enabled services, that reduce financial and administrative burdens to improve access, speed, and adherence to critical care.
Follow Us
CTI Biopharma
We are a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies for blood-related cancers that offer a unique benefit to patients and their healthcare providers. We concentrate our efforts on treatments that target blood-related cancers where there is an unmet medical need. In particular, we are focused on developing and commercializing pacritinib, our product candidate currently in active late-stage development. We are headquartered in Seattle, Washington.
Follow Us
Foundation Medicine
Follow Us
EMD Serono
EMD Serono-the healthcare business of Merck KGaA, Darmstadt, Germany in the U.S. and Canada-aspires to create, improve and prolong life for people living with difficult-to-treat conditions like infertility, multiple sclerosis and cancer. The business is imagining the future of healthcare by working to translate the discovery of molecules into potentially meaningful outcomes for people with serious unmet medical needs. EMD Serono’s global roots go back more than 350 years with Merck KGaA,Darmstadt, Germany. Today, the business has more than 1,000 employees around the country with commercial, clinical and research operations in Massachusetts.
Follow Us
Florida Cancer Specialists
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past five years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with FCS participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
Follow Us
Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved milestones in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to developing and advancing innovative medicines to prevent and treat life-threatening diseases. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California. For more information on Gilead Sciences, please visit the company’s website at www.gilead.com.
Follow Us
Illumina
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data. Through collaborative innovation, Illumina is fueling ground breaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
Follow Us
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Novartis
Novartis is reimagining medicine to improve and extend people’s lives. We deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership inR&D and novel access approaches. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. About 106,000people of more than 140 nationalities work together to bring Novartis products to nearly 800million people around the worldFind out more at www.novartis.com
RxVantage
RxVantage is transforming the way physicians and their practice teams make healthcare connections that elevate the practice of medicine. The only all-in-one provider preferred engagement platform of its kind, RxVantage intelligently connects healthcare providers with resources including the precise life sciences experts that they need, when they need it and in a manner that fits seamlessly into their workflow.
Follow Us
Servier Pharmaceuticals
Servier Pharmaceuticals is a commercial-stage pharmaceuticals company with a passion for innovation and improving the lives of patients, their families and caregivers. In the United States, Servier Pharmaceuticals is committed to building a robust portfolio, starting with oncology, with future growth driven by innovation in other areas of unmet medical need, leveraging Servier’s global portfolio and seeking acquisitions, licensing deals and partnerships.
With our commercial and scientific expertise, global reach and commitment to clinical excellence, Servier Pharmaceuticals is dedicated to bringing the promise of tomorrow to the patients that we serve.
Follow Us
Stemline Therapeutics
Unlimited Systems
Unlimited Systems provides a platform for a wide range of specialty healthcare practices seeking measurable increases in staff productivity, cash flow, and revenue with their feature product Unlimited Financials. Unlimited Financials is a full-featured revenue cycle platform with detailed analytics and task-driven workflows from start to finish. Specialty healthcare practices using Unlimited Financials can be confident that they will achieve peak financial performance.
Follow Us
Viatris
We believe in healthcare as it should be – empowering people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and scientific expertise and proven commercial capabilities to bring quality medicines to patients when and where they need them.
Follow Us
Thank you
Amgen
Follow Us
AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit www.astrazeneca-us.com and follow the Company on Twitter @AstraZenecaUS.
Follow Us
Canopy
The first Intelligent Care Platform for oncology, Canopy provides practices and life sciences organizations with intelligent solutions for proactive, outcome-based care. Canopy’s comprehensive and EMR-integrated suite of products includes ePRO-based Patient Monitoring (ePROs), Oral Oncolytics solutions, clinical workflow and patient engagement tools, as well as automated billing, reimbursement capture, and advanced analytics.
Follow Us
CardinalHealth
CureMD
Our award-winning solutions simplify decision making, streamline operations, and ensure compliance with industry standards and best practices; ultimately saving time and effort to maximize value and returns.
Follow Us
Exact Sciences
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to take on some of the deadliest cancers and improve patient care. Exact Sciences unites visionary collaborators to help advance the fight against cancer.
Follow Us
Florida Cancer Specialists
Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. Over the past five years, the majority of new cancer drugs approved for use in the U.S. were studied in clinical trials with FCS participation.* Trained in such prestigious medical schools and research institutes as Duke, Stanford, Harvard, Emory, MD Anderson, and Memorial Sloan Kettering, our physicians are consistently ranked nationally as Top Doctors by U.S. News & World Report.
FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies, genomic-based treatment and immunotherapy. Our values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians, and staff.
Follow Us
Janssen
At Janssen, we’re creating a future where disease is a thing of the past.We’re thePharmaceutical Companies of Johnson & Johnson, working tirelessly to make that future a reality for patients everywhere by fighting sickness with science, improving access within genuity, and healing hopelessness with heart.
Follow Us
Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to developing medicines for people with serious diseases — often with limited or no options.
LeanTaaS
LeanTaaS develops software that increases patient access to medical care by optimizing how health systems use expensive, constrained resources like infusion chairs, operating rooms, and inpatient beds. More than 120 health systems and 485 hospitals – including 40% of the top 25 health systems in the country, based on net patient revenue, 80% of all National Comprehensive Cancer Network institutions, and 55% of all National Cancer Institute locations – rely on the company’s iQueue cloud-based platform to increase patient access, decrease wait times, and reduce healthcare delivery costs. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina.
Follow Us
McKesson
Follow McKesson
Follow The US Oncology Network
Mirati Therapeutics
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. Unified for patients, Mirati’s vision is to unlock the science behind the promise of a life beyond cancer.
Follow Us
Organon
Organon is a global healthcare company formed to focus on improving the health of women throughout their lives. Organon has a portfolio of more than 60 medicines and products across a range of therapeutic areas led by the women’s health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines.
Follow Us
Sanofi
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to help improve people’s lives. We are working to advance potentially transformative therapies to help people with cancer. Our current work and research focuses on lung, prostate, multiple myeloma and other blood cancers. We take bold steps every day to advance our pipeline and seek solutions that help address critical gaps in care across a variety of difficult-to-treat cancers. Our oncology strategy focuses on developing a portfolio of high-quality assets that we believe will have the potential to improve oncology care.
Thyme Care
Thyme Care is an oncology population management platform that provides personalized, clinically coordinated care navigation to individuals with cancer. Our multidisciplinary care team, which includes oncology nurses, and digital care delivery platform serve as an extension of the practices we work with, unlocking practice staff efficiency and paving the way for their success in value-based care models. We partner with community oncology practices to enhance care coordination and ensure timely patient access to high-value oncologists, and currently have 220oncology provider partners. Our unique approach allows us to extend beyond the four walls of the practice, improving patient experience and outcomes, enhancing team efficiency and aligning incentives across stakeholders.
Follow Us
Stay up to date with all the latest & greatest news about the conference!
Sign up for the Community Oncology Conference newsletter today and never miss out on the newest updates regarding the event.
